Logo

Interleukin Genetics, Alticor Expand Genetic Test License Agreement

Sep 04, 2008
NEW YORK (GenomeWeb News) – Interleukin Genetics said today it has expanded an agreement with Alticor division Access Business Group giving both companies increased access to genetic tests that the two companies have developed together under research programs.
 
Under the agreement, the existing license that ABG holds to Interleukin Genetics’ intellectual property will become non-exclusive, the company said. Interleukin Genetics will gain the right to brand, market, sell, and distribute all genetic tests developed using existing and future intellectual property.
 
ABG also will continue to distribute the Heart Health and General Nutrition genetic tests under the Gensona brand name, and Interleukin Genetics will continue to have exclusive ownership of all of the inventions relating to genetic tests stemming from the two companies’ programs.

Breaking News
The Scan

Cell Signaling Pathway Identified as Metastasis Suppressor

A new study in Nature homes in on the STING pathway as a suppressor of metastasis in a mouse model of lung cancer.

Using Bees to Gain Insights into Urban Microbiomes

As bees buzz around, they pick up debris that provides insight into the metagenome of their surroundings, researchers report in Environmental Microbiome.

Age, Genetic Risk Tied to Blood Lipid Changes in New Study

A study appearing in JAMA Network Open suggests strategies to address high lipid levels should focus on individuals with high genetic risk and at specific ages.

Study Examines Insights Gained by Adjunct Trio RNA Sequencing in Complex Pediatric Disease Cases

Researchers in AJHG explore the diagnostic utility of adding parent-child RNA-seq to genome sequencing in dozens of families with complex, undiagnosed genetic disease.